
Former Miss Hong Kong Nathalie Ng’s Battle with Stage Four Cancer Takes a Turn
2025-03-22
Author: Wei
Nathalie Ng, the beloved former Miss Hong Kong second runner-up, is facing a daunting challenge as her fight against breast cancer has escalated to stage four. The 30-year-old beauty queen revealed that cancer cells have metastasized to her coccyx, necessitating urgent medical action.
In an emotional statement, Nathalie shared the shocking news of her condition's progression, stating, "The cells have mutated and moved to my coccyx, which is why it has reached stage four. I had to undergo five sessions of radiotherapy focused on my coccyx while I was hospitalized."
In addition to the metastasis, Ng also reported a concerning growth in the tumor located in her left breast. "The tumor has increased significantly in size, alarming me enough to begin chemotherapy as part of my treatment regimen," she explained. Just two weeks post-hospitalization, she has committed to weekly chemotherapy sessions to combat the aggressive nature of her illness.
To complement her chemotherapy, Ng is exploring alternative treatments aimed at boosting her immune system and easing the side effects associated with conventional cancer therapies. “I am surprised by the positive results I’ve started to see,” she noted, expressing a cautious sense of hope in her fight against the disease.
Nathalie Ng is determined to share her journey and experiences through social media. She plans to host a live session soon, where she hopes to inspire others facing similar battles. “It’s okay! Stage four can improve! Don’t be afraid! Fear means defeat!” she encouraged, showcasing her relentless spirit in the face of adversity.
Ng’s resilience and willingness to confront this ordeal head-on reflect a deeper message about the importance of support, awareness, and advocacy for those battling similar health issues. As she embarks on the next phase of her treatment, her supporters and fans are rallying behind her, hoping for a turnaround in her battle against cancer.